These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34291991)

  • 1. Verbal behavior related to drug reinforcement in polysubstance cannabis users: Comparison across drugs.
    Cox DJ; Johnson MW
    Exp Clin Psychopharmacol; 2022 Apr; 30(2):172-179. PubMed ID: 34291991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.
    Licht CL; Christoffersen M; Okholm M; Damgaard L; Fink-Jensen A; Knudsen GM; Erritzoe D
    Hum Psychopharmacol; 2012 Jul; 27(4):352-63. PubMed ID: 22696164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDMA: interactions with other psychoactive drugs.
    Mohamed WM; Ben Hamida S; Cassel JC; de Vasconcelos AP; Jones BC
    Pharmacol Biochem Behav; 2011 Oct; 99(4):759-74. PubMed ID: 21756931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the heterogeneity of polysubstance use patterns in young adulthood by age and college attendance.
    Stevens AK; Gunn RL; Sokolovsky AW; Colby SM; Jackson KM
    Exp Clin Psychopharmacol; 2022 Oct; 30(5):701-713. PubMed ID: 33970653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
    Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J
    Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The harmful health effects of recreational ecstasy: a systematic review of observational evidence.
    Rogers G; Elston J; Garside R; Roome C; Taylor R; Younger P; Zawada A; Somerville M
    Health Technol Assess; 2009 Jan; 13(6):iii-iv, ix-xii, 1-315. PubMed ID: 19195429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
    Taurah L; Chandler C; Sanders G
    Psychopharmacology (Berl); 2014 Feb; 231(4):737-51. PubMed ID: 24114426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine).
    Ho E; Karimi-Tabesh L; Koren G
    Neurotoxicol Teratol; 2001; 23(6):561-7. PubMed ID: 11792525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment.
    Bhattachary S; Powell JH
    Psychol Med; 2001 May; 31(4):647-58. PubMed ID: 11352367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-related decrease in neuropsychological functions of abstinent drug users.
    van Holst RJ; Schilt T
    Curr Drug Abuse Rev; 2011 Mar; 4(1):42-56. PubMed ID: 21466500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study.
    Raj V; Liang HC; Woodward ND; Bauernfeind AL; Lee J; Dietrich MS; Park S; Cowan RL
    J Psychopharmacol; 2010 Feb; 24(2):187-201. PubMed ID: 19304866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study.
    Cowan RL; Joers JM; Dietrich MS
    Pharmacol Biochem Behav; 2009 Mar; 92(1):105-10. PubMed ID: 19032963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
    Bedi G; Van Dam NT; Redman J
    J Psychopharmacol; 2010 Feb; 24(2):233-40. PubMed ID: 18832429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study.
    Moore DG; Turner JD; Parrott AC; Goodwin JE; Fulton SE; Min MO; Fox HC; Braddick FM; Axelsson EL; Lynch S; Ribeiro H; Frostick CJ; Singer LT
    J Psychopharmacol; 2010 Sep; 24(9):1403-10. PubMed ID: 19939863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ecstasy and new patterns of drug use: a normal population study.
    Pedersen W; Skrondal A
    Addiction; 1999 Nov; 94(11):1695-706. PubMed ID: 10892008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing patterns and correlates of population-level polysubstance use in Australian youth: a multi-group latent class analysis of nationally representative samples spanning 12 years.
    Chan G; Connor J; Hall W; Leung J
    Addiction; 2020 Jan; 115(1):145-155. PubMed ID: 31357251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive performance amongst recreational users of "ecstasy".
    Rodgers J
    Psychopharmacology (Berl); 2000 Jul; 151(1):19-24. PubMed ID: 10958112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
    Schilt T; de Win MM; Jager G; Koeter MW; Ramsey NF; Schmand B; van den Brink W
    Psychol Med; 2008 Sep; 38(9):1309-17. PubMed ID: 17988417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prepulse inhibition and habituation of acoustic startle response in male MDMA ('ecstasy') users, cannabis users, and healthy controls.
    Quednow BB; Kühn KU; Hoenig K; Maier W; Wagner M
    Neuropsychopharmacology; 2004 May; 29(5):982-90. PubMed ID: 14970829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent Classes of Substance Use in Young Adults - A Systematic Review.
    de Jonge MC; Bukman AJ; van Leeuwen L; Onrust SA; Kleinjan M
    Subst Use Misuse; 2022; 57(5):769-785. PubMed ID: 35188870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.